Template:BerkiGEM2007 WikiPlaying
From 2007.igem.org
(Difference between revisions)
| Line 11: | Line 11: | ||
h1.firstHeading {display: none;} | h1.firstHeading {display: none;} | ||
#navmenu { | #navmenu { | ||
| - | float: | + | float: center; |
width: 900px; | width: 900px; | ||
position: absolute; | position: absolute; | ||
| Line 19: | Line 19: | ||
z-index:50; | z-index:50; | ||
margin-bottom: 0px; | margin-bottom: 0px; | ||
| + | background-image: white; | ||
} | } | ||
| Line 88: | Line 89: | ||
color: #FF0000; | color: #FF0000; | ||
} | } | ||
| + | |||
| + | .style1 { | ||
| + | color: #0000FF; | ||
| + | font-weight: bold; | ||
| + | } | ||
| + | .style4 {color: #0000FF; font-weight: bold; font-size: large; } | ||
| + | .style5 {font-size: medium} | ||
| + | .style9 {font-size: large; color: #0000FF;} | ||
| + | .style10 {font-size: medium; color: #0000FF; } | ||
| + | .style11 {color: #0000FF; font-weight: bold; font-size: medium; } | ||
</style> | </style> | ||
| + | |||
| Line 389: | Line 401: | ||
<body> | <body> | ||
| - | |||
<div id="apDiv4"><img src="https://static.igem.org/mediawiki/2007/8/8e/Red_Bacterium_With_Link_LinesV5.gif" alt="" name="RedBacterium" width="595" height="600" id="RedBacterium" /></div> | <div id="apDiv4"><img src="https://static.igem.org/mediawiki/2007/8/8e/Red_Bacterium_With_Link_LinesV5.gif" alt="" name="RedBacterium" width="595" height="600" id="RedBacterium" /></div> | ||
<div id="apDiv6"> | <div id="apDiv6"> | ||
Revision as of 07:29, 7 October 2007
Hello, Where is this being put?
Hello, Where is this being put?
Oxygen Transport
Immunity
Storage
System Controller
Kill Switch
Antioxidants
Growth Control
The global demand and importance for cheap, available, and disease free blood substitutes is undisputed. There are currently no red blood cell substitutes approved for clinical use in the US or the UK, and whole blood is almost always in short supply. Underdeveloped countries that need blood the most simply don’t have the infrastructure to support donation and storage, in addition a sizeable fraction of the population are disease carriers. We are developing an innovative and cheap blood substitute based on engineered E. coli with all the critical properties of human erythrocytes. These include the ability to safely exist in the bloodstream, carry oxygen, and be stored for prolonged periods in a freeze-dried state.
